Decreased TCA cycle rate in the rat brain after acute 3-NP treatment measured by in vivo 1H-{13C} NMR spectroscopy

被引:46
作者
Henry, PG
Lebon, V
Vaufrey, F
Brouillet, E
Hantraye, P
Bloch, G
机构
[1] Serv Hosp Frederic Joliot, CEA, F-91401 Orsay, France
[2] Serv Hosp Frederic Joliot, UMR CEA CNRS 2210, F-91401 Orsay, France
关键词
brain; C-13 NMR spectroscopy; glutamate; 3-nitropropionic acid; rat; TCA cycle;
D O I
10.1046/j.1471-4159.2002.01006.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inhibition of succinate dehydrogenase (SDH) by the mitochondrial toxin 3-nitropropionic acid (3-NP) has gained acceptance as an animal model of Huntington's disease. In this study (13) C NMR spectroscopy was used to measure the tricarboxylic acid (TCA) cycle rate in the rat brain after 3-NP treatment. The time course of both glutamate C4 and C3 (13) C labelling was monitored in vivo during an infusion of [1-(13) C]glucose. Data were fitted by a mathematical model to yield the TCA cycle rate (V-tca ) and the exchange rate between alpha-ketoglutarate and glutamate (V (x) ). 3-NP treatment induced a 18% decrease in V-tca from 0.71 +/- 0.02 mumol/g/min in the control group to 0.58 +/- 0.02 mumol/g/min in the 3-NP group (p < 0.001). V (x) increased from 0.88 +/- 0.08 mumol/g/min in the control group to 1.33 +/- 0.24 mumol/g/min in the 3-NP group (p < 0.07). Fitting the C4 glutamate time course alone under the assumption that V-x is much higher than V-tca yielded V-tca =0.43 mumol/g/min in both groups. These results suggest that both V-tca and V-x are altered during 3-NP treatment, and that both glutamate C4 and C3 labelling time courses are necessary to obtain a reliable measurement of V-tca .
引用
收藏
页码:857 / 866
页数:10
相关论文
共 39 条
[1]  
[Anonymous], 1991, HUNTINGTONS DIS
[2]   Energetics in the pathogenesis of neurodegenerative diseases [J].
Beal, MF .
TRENDS IN NEUROSCIENCES, 2000, 23 (07) :298-304
[3]  
BEAL MF, 1993, J NEUROSCI, V13, P4181
[4]   1-13C glucose magnetic resonance spectroscopy of pediatric and adult brain disorders [J].
Blüml, S ;
Moreno, A ;
Hwang, JH ;
Ross, BD .
NMR IN BIOMEDICINE, 2001, 14 (01) :19-32
[5]  
Brouillet E, 1998, J NEUROCHEM, V70, P794
[6]   Replicating Huntington's disease phenotype in experimental animals [J].
Brouillet, E ;
Condé, F ;
Beal, MF ;
Hantraye, P .
PROGRESS IN NEUROBIOLOGY, 1999, 59 (05) :427-468
[7]  
CHANCE EM, 1983, J BIOL CHEM, V258, P3785
[8]  
Chen W, 2001, MAGN RESON MED, V45, P349, DOI 10.1002/1522-2594(200103)45:3<349::AID-MRM1045>3.0.CO
[9]  
2-8
[10]   In vivo measurements of brain glucose transport using the reversible Michaelis-Menten model and simultaneous measurements of cerebral blood flow changes during hypoglycemia [J].
Choi, IY ;
Lee, SP ;
Kim, SG ;
Gruetter, R .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (06) :653-663